We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MRC Technology Launches Respiratory ‘Call for Targets’

News   Mar 02, 2015

 
MRC Technology Launches Respiratory ‘Call for Targets’
 
 
Advertisement
 

RELATED ARTICLES

NIH Announces Clinical Trial To Test Monoclonal Antibodies for COVID-19

News

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.

READ MORE

RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19

News

A clinical trial of RLF-100 (aviptadil) has shown rapid recovery from respiratory failure in critically ill patients with COVID-19.

READ MORE

Nose Study Sniffs Out the Origins of Parkinson's Disease

News

New research into the origins of Parkinson’s disease has identified a critical signaling molecule that may be key to the domino effect kicked off by nasal inflammation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE